New Financial Statements From 2010 to 2024

NNH Stock  SEK 15.00  0.10  0.66%   
New Nordic financial statements provide useful quarterly and yearly information to potential New Nordic Healthbrands investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on New Nordic financial statements helps investors assess New Nordic's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting New Nordic's valuation are summarized below:
New Nordic Healthbrands does not presently have any fundamental ratios for analysis.
Check New Nordic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among New Nordic's main balance sheet or income statement drivers, such as , as well as many indicators such as . New financial statements analysis is a perfect complement when working with New Nordic Valuation or Volatility modules.
  
This module can also supplement various New Nordic Technical models . Check out the analysis of New Nordic Correlation against competitors.

New Nordic Healthbrands Company Return On Equity Analysis

New Nordic's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current New Nordic Return On Equity

    
  -0.0316  
Most of New Nordic's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, New Nordic Healthbrands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, New Nordic Healthbrands has a Return On Equity of -0.0316. This is 99.87% lower than that of the Healthcare sector and 109.03% lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on equity for all Sweden stocks is 89.81% lower than that of the firm.

New Nordic Healthbrands Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining New Nordic's current stock value. Our valuation model uses many indicators to compare New Nordic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across New Nordic competition to find correlations between indicators driving New Nordic's intrinsic value. More Info.
New Nordic Healthbrands is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the New Nordic's earnings, one of the primary drivers of an investment's value.

About New Nordic Financial Statements

New Nordic shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although New Nordic investors may analyze each financial statement separately, they are all interrelated. The changes in New Nordic's assets and liabilities, for example, are also reflected in the revenues and expenses on on New Nordic's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
New Nordic Healthbrands AB develops and markets branded food supplements, natural remedies, and related personal care products. New Nordic Healthbrands AB was founded in 1990 and is based in Malm, Sweden. New Nordic operates under Healthcare Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 49 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for New Stock Analysis

When running New Nordic's price analysis, check to measure New Nordic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy New Nordic is operating at the current time. Most of New Nordic's value examination focuses on studying past and present price action to predict the probability of New Nordic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move New Nordic's price. Additionally, you may evaluate how the addition of New Nordic to your portfolios can decrease your overall portfolio volatility.